Biliary tract cancer exhibits immunogenic features, including expression of the immune checkpoint molecules programmed death ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) in the tumor microenvironment [6,7]. This evidence concerns the gene CTLA4 and biliary tract cancer.